Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 3rd Quarter - Report

AMNEAL PHARMACEUTICAL

via MICHAEL BEST STRATEGIES LLC

3rd Quarter (July 1 - Sep 30) · 2021Posted Oct 19, 2021Filing document ↗LDA record ↗

Income$60Kfee reported

Client

Name: AMNEAL PHARMACEUTICAL
Description: pharmaceutical company
Location: New Jersey · United States of America

Registrant

Firm: MICHAEL BEST STRATEGIES LLC
Description: Government Relations Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
issues related to reshoring pharmaceutical supply chain
LobbyistsDENISE BODE · ALEXANDER ANGELSON · LUCIA ALONZO · ANDREA RICCIO
Covered position (ALEXANDER ANGELSON): Special Assistant to the President, White House Legislative Affairs
Covered position (ANDREA RICCIO): Deputy Director Democratic Policy and Communications Committee, House of Representatives
TargetedWhite House Office

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

AMNEAL PHARMACEUTICAL — Lobbying — Receipts Report